Related references
Note: Only part of the references are listed.The Angiogenic Factor Secretoneurin Induces Coronary Angiogenesis in a Model of Myocardial Infarction by Stimulation of Vascular Endothelial Growth Factor Signaling in Endothelial Cells
Karin Albrecht-Schgoer et al.
CIRCULATION (2012)
Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells
Tom T. Chen et al.
JOURNAL OF CELL BIOLOGY (2010)
1-tert-Butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)- pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a Selective Tyrosine Kinase Inhibitor of Fibroblast Growth Factor Receptor-3 (FGFR3), Inhibits Cell Proliferation of Bladder Cancer Carrying the FGFR3 Gene Mutation along with Up-Regulation of p27/Kip1 and G1/G0 Arrest
Makito Miyake et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Gene Therapy With the Angiogenic Cytokine Secretoneurin Induces Therapeutic Angiogenesis by a Nitric Oxide-Dependent Mechanism
Wilfried Schgoer et al.
CIRCULATION RESEARCH (2009)
Wound repair and regeneration
Geoffrey C. Gurtner et al.
NATURE (2008)
Lentiviral gene transfer of SDF-1 α to wounds improves diabetic wound healing
Andrea T. Badillo et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1α- and basic FGF-dependent pathway in muscle cells
Margot Egger et al.
FASEB JOURNAL (2007)
Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor
Cecelia C. Yates et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Placenta growth factor in diabetic wound healing - Altered expression and therapeutic potential
Francesca Cianfarani et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers
Hanna Galkowska et al.
WOUND REPAIR AND REGENERATION (2006)
Wound healing and its impairment in the diabetic foot
V Falanga
LANCET (2005)
The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo
R Kirchmair et al.
CIRCULATION (2004)
Protective effects of a free radical scavenger, MCI-186, on high-glucose-induced dysfunction of human dermal microvascular endothelial cells
D Jiaojun et al.
WOUND REPAIR AND REGENERATION (2004)
Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells
RD Galiano et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma
S Trudel et al.
BLOOD (2004)
HoxD3 accelerates wound healing in diabetic mice
SL Hansen et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Molecular understanding of hyperglycemia's adverse effects for diabetic complications
MJ Sheetz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Recombinant AAV vector encoding human VEGF165 enhances wound healing
B Deodato et al.
GENE THERAPY (2002)
Immunoassay for measuring the heparin-binding growth factors HARP and MK in biological fluids
P Soulié et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2002)
Improvements in gene therapy - Averting the immune response to adenoviral vectors
T Ritter et al.
BIODRUGS (2002)
Share Paper
